A Master Protocol to Evaluate the Safety, Tolerability, and Efficacy of Islet Cell Replacement Therapies in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia: A Phase 1/2/3 Study of VX-880 and a Phase 1/2 Study of VX-017
This clinical trial is testing special cell therapies called VX-880 and VX-017 for people with Type 1 diabetes. These treatments aim to help the body make its own insulin again, which could help patients who struggle to feel when their blood sugar drops dangerously low.
You might be able to join if you have had Type 1 diabetes and used insulin for at least 5 years. You also need to have experienced severe episodes of low blood sugar recently and be willing to use a continuous glucose monitor.
Participants will receive one of the study treatments designed to replace insulin-producing cells. Your health team will closely monitor your blood sugar and overall well-being throughout the study to see how well the therapy works.
The study is currently recruiting participants at locations in California and Florida. You can talk to the study team to see which location is most convenient for you.
- 1Testing new cell therapies to help the body produce insulin naturally
- 2Designed for adults with Type 1 diabetes and severe low blood sugar episodes
- 3Currently recruiting patients at select locations in the United States
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.